• Arcutis Biotherapeutics' (ARQT) Buy Rating Reaffirmed at Guggenheim

    Source: Buzz FX / 10 Feb 2025 10:12:10   America/New_York


    Arcutis Biotherapeutics' (ARQT) Buy Rating Reaffirmed at Guggenheim Written by MarketBeat February 10, 2025 Share Link copied to clipboard. Arcutis Biotherapeutics ( NASDAQ:ARQT - Get Free Report ) 's stock had its "buy" rating reaffirmed b
    Read more...
Share on,